Results 11 to 20 of about 766,404 (301)

Treatment resistant depression in women with peripartum depression [PDF]

open access: yesBMC Pregnancy and Childbirth, 2019
Background Peripartum depression is a leading cause of disease burden for women and yet there is little evidence as to how often peripartum depression does not respond to treatment and becomes treatment resistant depression.
M. Soledad Cepeda   +2 more
doaj   +3 more sources

Ketamine for treatment resistant depression in individuals with eating disorders: a comparison study [PDF]

open access: yesJournal of Eating Disorders
Background Individuals with eating disorders (EDs) have an increased risk of treatment resistant depression (TRD) and treatment resistant bipolar disorder (TRBD) and a higher rate of suicidal ideation and death by suicide than individuals without EDs ...
Elizabeth Wassenaar   +7 more
doaj   +2 more sources

Defining treatment‐resistant depression

open access: yesDepression and Anxiety, 2019
Varying conceptualizations of treatment‐resistant depression (TRD) have made translating research findings or systematic reviews into clinical practice guidelines challenging and inconsistent.
B. Gaynes   +12 more
semanticscholar   +3 more sources

Ketamine in treatment-resistant depression

open access: yesIndustrial Psychiatry Journal
Sana Dhamija   +2 more
doaj   +5 more sources

Effects of psilocybin-assisted therapy on treatment-resistant depression

open access: yesEuropean Psychiatry, 2021
Introduction Major depressive disorder is a highly prevalent clinical condition, affecting more than 300 million individuals worldwide. About 1/3 of patients with MDD fail to achieve remission despite treatment with multiple antidepressants and are ...
A. Fraga   +7 more
doaj   +1 more source

The Prevalence and National Burden of Treatment-Resistant Depression and Major Depressive Disorder in the United States.

open access: yesJournal of Clinical Psychiatry, 2021
OBJECTIVE Estimates of prevalence and burden of treatment-resistant depression (TRD) vary widely in the literature. This study evaluated the prevalence and burden of TRD and the share of TRD in the burden of medication-treated major depressive disorder ...
M. Zhdanava   +6 more
semanticscholar   +1 more source

Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication

open access: yesNeuropsychopharmacology, 2023
Psilocybin is being investigated as a treatment in adults with treatment-resistant depression (TRD). Withdrawal from serotonergic antidepressant drugs is a common prerequisite for taking part in trials of psilocybin due to the possibility of ongoing ...
G. Goodwin   +13 more
semanticscholar   +1 more source

Is treatment resistant depression a different subtype of depression?

open access: yesEuropean Psychiatry, 2021
Major depression is a serious, disabling, often chronic or recurrent mental disorder affecting over 350 million people worldwide. Treatment of major depression is now conceptualized as proceeding through three phases: the acute phase, the continuation ...
A. Fiorillo
doaj   +1 more source

Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study

open access: yesNeuropsychopharmacology, 2023
Patients with treatment-resistant depression (TRD) have higher rates of relapse and pronounced decreases in daily functioning and health-related quality of life compared to patients with major depressive disorder who are not treatment-resistant ...
N. Zaki   +9 more
semanticscholar   +1 more source

Use of pharmacotherapies for treatment resistant depression in finland: A nationwide cohort study

open access: yesEuropean Psychiatry, 2021
Introduction There is a lack of knowledge on utilized pharmacotherapies for treatment resistant depression (TRD). Objectives To investigate the courses of treatment of TRD.
H. Taipale   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy